PhD Program Presentation Video

PhD Program Presentation Video

The PhD Program in Translational Molecular Medicine and Surgery at the University of Messina is a high-level scientific training program aimed at developing advanced skills in translational biomedical research. The program was designed to train researchers capable of integrating basic science, clinical research, and technological innovation, promoting the transfer of scientific knowledge from laboratory experimentation to clinical practice (“bench to bedside”). The educational project is fully aligned with the ANVUR guidelines for doctoral quality assurance and is characterized by a strong interdisciplinary approach, involving fields such as molecular biology, clinical medicine, pharmacology, bioinformatics, and digital technologies applied to health.

The training pathway, which lasts three years and corresponds to 180 ECTS credits, combines advanced teaching activities, specialized seminars, and intensive experimental research in qualified laboratories. PhD candidates are involved in competitive scientific projects and actively participate in scientific production, presenting results at national and international conferences and publishing in indexed journals. The program also promotes international mobility through collaborations with high-profile universities and research centers, encouraging research periods abroad and joint supervision or European doctoral degree programs.

A distinctive feature of the PhD program is the integration between academia, research institutions, and the biomedical industry, allowing doctoral candidates to acquire methodological and professional skills applicable both in the academic environment and in applied research and innovation sectors. Thanks to a strong network of scientific collaborations and a structured system of mentoring and activity monitoring, the program aims to train independent researchers capable of designing and conducting complex scientific studies and contributing to the development of personalized medicine and new biomedical technologies.